Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00796029 | A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose | PHASE1 | COMPLETED | 5 | — | — | Jul 1, 2003 | Jul 1, 2003 | Jun 8, 2011 | - | — |
| Name | Type | Description |
|---|---|---|
| 14C-paliperidone | DRUG | - |
Inclusion Criteria: * Dextromethorphan metabolic ratio of \>0.345 (poor metabolizer) or \<0.0255 (extensive metabolizer) * Body Mass Index: (weight \[kg\]/height \[m\]2) between 20 and 28 kg/m2, inclusive * Volunteers must have signed an informed consent document indicating that they understand the...